Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Patient Openness to Research Can Depend on Race and Sex of Study Personnel

Published: Monday, May 20, 2013
Last Updated: Monday, May 20, 2013
Bookmark and Share
Researchers have found that the race and sex of study personnel can influence a patient’s decision on whether or not to participate in clinical research.

The study, presented today at the Society for Academic Emergency Medicine’s annual meeting in Atlanta, that there is an interaction of the race and sex of the study assistant and the race of the patient.

Lead author Kimberly Hart says that her team found that black patients, both male and female, were about 15 percent less likely to be willing to participate in research when approached by a white male study assistant, compared to white patients.

However, black patients were about 15 percent more likely to be willing when approached by a white female study assistant. Conversely, black patients were about 50 percent less likely to be willing to participate in research when approached by a black female study assistant, compared to white patients.

The study builds on previous UC research reporting that black and female patients are less likely to agree to participate in research, despite being offered more frequent opportunities to participate.

"Social theories about relationships between medical providers or researchers and patients suggest that patients may have more trust in providers who are similar to them in terms of gender and race, but there are few research studies that directly address race and sex differences between medical researchers and patient participants,” says Hart, a research associate in the department of emergency medicine. "Our team hypothesized that when a patient was approached by a study assistant of the same race or sex, the patient would be more willing to participate than when race and sex were different.”

To test this, the team studied nearly 160,000 patients screened for clinical research by 89 different study assistants at the UC Medical Center emergency department and Jewish Hospital emergency department from January 2007 to December 2011.

The patient population was 60 percent white and 44 percent male, while the study assistants were 75 percent white and 44 percent male. Most patients, 89 percent, were willing to be approached for research.

"We found that willingness to participate in research is influenced by the race and sex of the study assistant, but the impact is different for different groups,” says Hart. "As researchers, we should be aware of the impact of race and sex on our relationships with study participants. The relationship is much more complicated than we thought it would be, and we hope to conduct further research to better understand the reasons behind our observations. It is important to ensure equal representation of all persons in clinical research and only by understanding the factors that influence willingness to participate can we begin to prevent bias.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!